Literature DB >> 5642465

The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.

P A Ward, E L Becker.   

Abstract

As shown previously, immune complexes engender in rabbit serum a factor capable of inducing chemotaxis of rabbit polymorphonuclear leukocytes. This chemotactic factor consists of a complex of the fifth, sixth, and seventh components of complement. As demonstrated here, the polymorphonuclear leukocytes incubated with such treated rabbit serum lose their ability to respond chemotactically to the chemotactic factor. They are "deactivated." The process of "deactivation" is a function of the duration of contact of the cells with, and the concentration of, the treated serum. There is a parallelism between the time course of deactivation and of chemotaxis, as well as the dose-response curves for the two processes. Chemotactic factor purified by isoelectric precipitation and ion-exchange chromatography produces deactivation in the same manner as the treated serum. The deactivating activity requires, as does the chemotactic factor, the sixth component of complement; like the chemotactic factor, it is heat-stable and nondialyzable. Deactivation is prevented by the same phosphonate esters shown previously to prevent chemotaxis by the complement-associated chemotactic factor. The profiles of the phosphonates in protecting against deactivation are the same as the profiles for the chemotactic factor-dependent inhibition of chemotaxis. Aromatic amino acid derivatives prevent both chemotaxis and deactivation. We conclude from this evidence that the chemotactic factor is able to deactivate or induce chemotaxis depending upon experimental conditions. The fact that the profiles given by the phosphonates for protection against chemotactic factor-dependent deactivation and for chemotactic factor-dependent inhibition of chemotaxis are the same indicates that the "activatable esterase" is involved in both processes. Acetate esters such as ethyl acetate and others shown previously to prevent chemotaxis by inhibiting the "activated esterase" do not prevent deactivation. This indicates that deactivation can occur without participation of the latter enzyme, implying that deactivation involves only a part of the biochemical mechanism of chemotaxis. The protection against deactivation afforded by aromatic amino acid derivatives is specific, insofar as nonaromatic amino compounds and simple acetate esters have no effect. In addition, as stated, the aromatic amino acid derivatives inhibit deactivation and chemotaxis by the chemotactic factor. This latter finding, together with the demonstration of the involvement of the activatable esterase in both deactivation and chemotaxis, suggests that the activatable esterase of the rabbit polymorphonuclear leukocyte is a serine esterase with a special affinity for aromatic amino acid derivatives.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5642465      PMCID: PMC2138469          DOI: 10.1084/jem.127.4.693

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  THE ENZYMATIC HYDROLYSIS OF P-NITROPHENYL ETHYL PHOSPHONATES BY MAMMALIAN PLASMAS.

Authors:  E L BECKER; J F BARBARO
Journal:  Biochem Pharmacol       Date:  1964-08       Impact factor: 5.858

2.  Inhibition of the anaphylactic reaction.

Authors:  J L MONGAR; H O SCHILD
Journal:  J Physiol       Date:  1957-02-15       Impact factor: 5.182

3.  Further studies on the chemotactic factor of complement and its formation in vivo.

Authors:  P A Ward; C G Cochrane; H J Muller-Eberhard
Journal:  Immunology       Date:  1966-08       Impact factor: 7.397

4.  BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS.

Authors:  P A WARD; C G COCHRANE
Journal:  J Exp Med       Date:  1965-02-01       Impact factor: 14.307

5.  Partial biochemical characterization of the activated esterase required in the complement-dependent chemotaxis of rabbit polymorphonuclear leukocytes.

Authors:  E L Becker; P A Ward
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

6.  Mechanisms of the inhibition of chemotaxis by phosphonate esters.

Authors:  P A Ward; E L Becker
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

7.  A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

Authors:  C G COCHRANE; E R UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

  7 in total
  85 in total

1.  Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.

Authors:  S Ruddy; K F Austen; E J Goetzl
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

2.  Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.

Authors:  R A Ezekowitz; S H Orkin; P E Newburger
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

3.  Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge.

Authors:  S I Wasserman; N A Soter; D M Center; K F Austen
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  Urate crystal-induced chemotactic factor: isolation and partial characterization.

Authors:  I Spilbert; A Gallacher; J M Mehta; B Mandell
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

5.  Changes in neutrophil surface phenotype during hemodialysis.

Authors:  K M Skubitz; J Butterfield; K Ma; A P Skubitz
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

6.  Cystic fibrosis ciliary dyskinesia substances and pulmonary disease. Effects of ciliary dyskinesia substances on neutrophil movement in vitro.

Authors:  G B Wilson; H H Fudenberg; M T Parise; E Floyd
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

7.  Receptor blockade as a mechanism of deactivation of human neutrophils by pepstatin and formyl-Met-Leu-Phe.

Authors:  I Spilberg; J Mehta; M A Muniain; L Simchowitz; J Atkinson
Journal:  Inflammation       Date:  1984-03       Impact factor: 4.092

8.  Production of chemotactic activity for polymorphonuclear leukocytes by cultured rat hepatocytes exposed to ethanol.

Authors:  H D Perez; F J Roll; D M Bissell; S Shak; I M Goldstein
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  Enhancement of human polymorphonuclear leukocyte adherence to plastic and endothelium by phorbol myristate acetate. Comparison with human C5a.

Authors:  R O Webster; R B Wysolmerski; D Lagunoff
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

10.  Motility and adhesiveness in human neutrophils. Effects of chemotactic factors.

Authors:  C W Smith; J C Hollers; R A Patrick; C Hassett
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.